SEC Filing | Amicus Therapeutics

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bloch Stephen M

(Last)

(First)

(Middle)

C/O CANAAN PARTNERS

285 RIVERSIDE AVENUE, SUITE 250

(Street)

WESTPORT

06880

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AMICUS THERAPEUTICS INC [ FOLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2007

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2007		C		1,976,967	A	⁽¹⁾	0	I	By Canaan Equity III, L.P.⁽²⁾
Common Stock	06/05/2007		C		73,823	A	⁽¹⁾	0	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series B Convertible Preferred Stock Warrant (right to buy)	$6.375	06/05/2007		X			7,859⁽⁴⁾	05/04/2004	⁽⁴⁾	Series B Convertible Preferred Stock	7,859	$0	0	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock Warrant (right to buy)	$6.375	06/05/2007		X			253⁽⁴⁾	05/04/2004	⁽⁴⁾	Series B Convertible Preferred Stock	253	$0	0	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series B Convertible Preferred Stock	⁽⁵⁾	06/05/2007		X		7,859		06/05/2007	⁽⁵⁾	Common Stock	7,859	$0	906,079	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock	⁽⁵⁾	06/05/2007		X		253		06/05/2007	⁽⁵⁾	Common Stock	253	$0	33,835	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			7,859	06/05/2007	⁽¹⁾	Common Stock	449,110	$0	898,220	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			16,771	06/05/2007	⁽¹⁾	Common Stock	16,771	$0	33,542	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			449,110	05/04/2004	⁽¹⁾	Common Stock	449,110	$0	449,110	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			16,771	05/04/2004	⁽¹⁾	Common Stock	16,771	$0	16,771	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			449,110	03/24/2005	⁽¹⁾	Common Stock	449,110	$0	0	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			16,771	03/24/2005	⁽¹⁾	Common Stock	16,771	$0	0	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series C Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			437,415	08/16/2005	⁽¹⁾	Common Stock	437,415	$0	437,415	I	By Canaan Equity III, L.P.⁽²⁾
Series C Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			16,334	08/16/2005	⁽¹⁾	Common Stock	16,334	$0	16,334	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series C Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			437,415	04/17/2006	⁽¹⁾	Common Stock	437,415	$0	0	I	By Canaan Equity III, L.P.⁽²⁾
Series C Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			16,334	04/17/2006	⁽¹⁾	Common Stock	16,334	$0	0	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series D Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			96,029	09/13/2006	⁽¹⁾	Common Stock	98,029	$0	98,029	I	By Canaan Equity III, L.P.⁽²⁾
Series D Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			3,660	09/13/2006	⁽¹⁾	Common Stock	3,660	$0	3,660	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series D Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			96,029	09/13/2006	⁽¹⁾	Common Stock	98,029	$0	0	I	By Canaan Equity III, L.P.⁽²⁾
Series D Convertible Preferred Stock	⁽¹⁾	06/05/2007		C			3,660	09/13/2006	⁽¹⁾	Common Stock	3,660	$0	0	I	By Canaan Equity III Entrepreneurs, L.L.C.⁽³⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		S			5,810⁽⁶⁾	⁽¹⁾	⁽¹⁾	Series B Convertible Preferred Stock	5,810	$15	0	I	By Canaan Equity III, L.P.⁽²⁾
Series B Convertible Preferred Stock	⁽¹⁾	06/05/2007		S			217⁽⁶⁾	⁽¹⁾	⁽¹⁾	Series B Convertible Preferred Stock	217	$15	0	I	By Canaan Equity III Entrepeneurs, L.L.C.⁽³⁾

Explanation of Responses:

1. Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Amicus Therapeutics, Inc. common stock on a one for one basis upon the closing of Amicus Therapeutics, Inc's initial public offering on June 5, 2007.

2. The reporting person is a member of Canaan Equity Partners III, LLC, which is the general partner of Canaan Equity III, L.P. Voting and investment power over these shares is exercised by the managers of Canaan Equity Partners III, LLC in its role as general partner of Canaan Equity III, L.P. The reporting person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purporses of Section 16 or for any other purpose.

3. The reporting person is a member of Canaan Equity Partners III, LLC, which is the general partner of Canaan Equity III Entrepreneurs, LLC. Voting and investment power over these shares is exercised by the managers of Canaan Equity Partners III, LLC. in its role as general partner of Canaan Equity III Entrepreneurs, LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

4. The warrants to purchase Series B Convertible Preferred Stock were automatically net exercised for shares of Series B Preferred Stock of the Issuer upon the closing of the Issuer's initial public offering on June 5, 2007.

5. Each share is convertible and will automatically convert on a one-for-one basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effectice registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date.

6. Represents shares of Series B Convertible Preferred Stock disposed of in connection with the net exercise of warrants.

	/s/ Stephen Bloch	06/07/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.